Angela Maas - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Angela Maas's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Angela Maas
Verified
Managing Editor, Atlantic Information Services
Washington
Beats
Information technology, Cybersecurity
Nothing is out of bounds.
Content
By Angela Maas Verified| MMIT (Managed Markets Insight & Technology)@ As manufacturers continue to bring more advanced therapies onto the U.S. market, payers are grappling with how to afford these agents. And while the products may be life-changing for some patients, they may not have the desired outcome in others, leaving payers on the hook for an unsuccessful treatment. This has resulted in various contracting opportunities, including warranties.
By Angela Maas Verified| MMIT (Managed Markets Insight & Technology)@ Although the FDA has approved five biosimilars of Regeneron Pharmaceuticals, Inc.’s best-selling Eylea (aflibercept), patent infringement lawsuits by the drugmaker have kept those competitors off the U.S. market — until now. Following a successful defense of its Pavblu (aflibercept-ayyh), Amgen Inc. recently launched the drug at risk. The agent is entering an increasingly crowded therapeutic class, but it’s one that’s also costly for payers, which may be seeking some savings, say industry experts.
By Angela Maas Verified| MMIT (Managed Markets Insight & Technology)@ As manufacturers continue to bring more advanced therapies onto the U.S. market, payers are grappling with how to afford these agents. And while the products may be life-changing for some patients, they may not have the desired outcome in others, leaving payers on the hook for an unsuccessful treatment. This has resulted in various contracting opportunities, including warranties.
Company Info
Atlantic Information Services
MMIT, or Managed Markets Insights & Technology, is a prominent provider of market access data, analytics, and insights in the pharmaceutical, healthcare, and payer sectors. Founded in 1994 and based in Yardley, Pennsylvania, MMIT partners with pharmaceutical companies, payers, providers, and pharmacies to facilitate the delivery of lifesaving therapies to patients. The company focuses on enhancing decision-making processes through clarity and confidence. MMIT offers a range of services, including market access data and analytics, consulting services, and insights through its journalism division, AIS Health. Their Zitter Insights Panel provides valuable research to help clients navigate market access complexities. The company is known for its collaborative culture and supports work-life balance with various benefits, including flexible work arrangements and enhanced vacation policies. MMIT values driven and agile team members who are encouraged to make a meaningful impact within the organization.
'+1 267-753-6800
Founded: 1994